Breaking News Instant updates and real-time market news.

WBA

Walgreens Boots Alliance

$54.40

-0.93 (-1.68%)

, CQP

Cheniere Energy Partners

$43.97

-0.42 (-0.95%)

10:09
10/23/19
10/23
10:09
10/23/19
10:09

Fly Intel: Top five analyst downgrades

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Walgreens Boots Alliance (WBA) downgraded to Neutral from Overweight at JPMorgan with analyst Lisa Gill saying she based on her relative rating methodology, seeing better opportunities for upside in other companies within her coverage universe at the current time. 2. Cheniere Energy Partners (CQP) downgraded to Underperform at Raymond James with analyst Justin Jenkins saying that while his firm's North American energy macro outlook remains favorable for exporters from a supply-push perspective, he sees this as priced into Cheniere shares. 3. Resideo (REZI) downgraded to Perform from Outperform at Oppenheimer with analyst Ian Zaffino saying the company, once again, revised guidance negatively. 4. ServiceNow (NOW) downgraded to Neutral from Buy at Mizuho with analyst Gregg Moskowitz saying the company last night surprisingly announced the impending departure of CEO John Donahoe, who is going to head Nike (NKE), and lowered its full year guidance due to currency. 5. Kohl's (KSS) downgraded to In Line from Outperform at Evercore ISI. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

WBA

Walgreens Boots Alliance

$54.40

-0.93 (-1.68%)

CQP

Cheniere Energy Partners

$43.97

-0.42 (-0.95%)

REZI

Resideo

$8.88

-6.29 (-41.46%)

NOW

ServiceNow

$224.99

-3.27 (-1.43%)

KSS

Kohl's

$52.30

-0.66 (-1.25%)

  • 23

    Oct

  • 28

    Oct

  • 19

    Nov

  • 04

    Dec

  • 09

    Dec

  • 12

    Dec

WBA Walgreens Boots Alliance
$54.40

-0.93 (-1.68%)

10/23/19
JPMS
10/23/19
DOWNGRADE
Target $63
JPMS
Neutral
Walgreens Boots Alliance downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Lisa Gill downgraded Walgreens Boots Alliance to Neutral from Overweight with a $63 price target.
09/11/19
DBAB
09/11/19
INITIATION
Target $53
DBAB
Sell
Walgreens Boots Alliance initiated with a Sell at Deutsche Bank
Deutsche Bank analyst George Hill initiated Walgreens Boots Alliance with a Sell rating and a price target of $53 as part of a broader research note on Healthcare Technology & Services. The analyst warns that the company's stand-alone pharmacy business strategy will face "unrelenting competitive and reimbursement pressure", which will likely yield negative earnings revisions. Hill adds that the current "punitive" multiple on the stock is warranted.
09/27/19
RBCM
09/27/19
INITIATION
Target $59
RBCM
Sector Perform
Walgreens Boots Alliance assumed with a Sector Perform at RBC Capital
RBC Capital analyst Anton Hie assumed coverage of Walgreens Boots Alliance with a Sector Perform rating and a price target of $59. The analyst is positive on the company's "strong national presence" and sees its efforts to leveraged its partners' expertise to broaden its capabilities as a smart move. However, Hie does not expect Walgreens shares to reach "significantly higher" multiples until the management offers a more specific strategic direction and evidence of "strong progress" with a higher earnings trajectory.
10/23/19
JPMS
10/23/19
DOWNGRADE
Target $63
JPMS
Neutral
JPMorgan downgrades Walgreens to Neutral ahead of fiscal 2020 outlook
JPMorgan analyst Lisa Gill downgraded Walgreens Boots Alliance to Neutral from Overweight with a price target of $63, down from $73. The analyst, based on her relative rating methodology, sees better opportunities for upside in other companies within her coverage universe at the current time. With Walgreens expected to provide fiscal 2020 guidance with Q4 results on October 28, its adjusted operating profit growth "will continue to remain challenged" in the near term, after a high-single digit decline in fiscal 2019, Gill tells investors in a pre-earnings research note. The analyst says that with growth taking longer to realize under the current strategy and limited clarity on the roadmap to improvement and few identifiable near term catalysts, she finds it difficult to justify on Overweight rating on Walgreens shares.
CQP Cheniere Energy Partners
$43.97

-0.42 (-0.95%)

10/23/19
RAJA
10/23/19
DOWNGRADE
RAJA
Underperform
Cheniere Energy Partners downgraded to Underperform at Raymond James
Raymond James analyst Justin Jenkins downgraded Cheniere Energy Partners to Underperform from Market Perform.
10/08/19
BERN
10/08/19
DOWNGRADE
BERN
Market Perform
Cheniere Energy Partners downgraded to Market Perform from Outperform at Bernstein
10/23/19
RAJA
10/23/19
DOWNGRADE
RAJA
Underperform
Cheniere Energy Partners downgraded to Underperform from Market Perform at Raymond James
Raymond James analyst Justin Jenkins downgraded Cheniere Energy Partners to Underperform from Market Perform. In a research note to investors, Jenkins says that while his firm's North American energy macro outlook remains favorable for exporters from a supply-push perspective, he sees this as priced into Cheniere shares. The analyst says he continues to monitor cash flow volatility and trade war headlines, but believes upside from here at the Cheniere level is fairly limited, even if project execution continues.
10/23/19
RAJA
10/23/19
UPGRADE
Target $71
RAJA
Outperform
Cheniere Energy upgraded to Outperform from Market Perform at Raymond James
Raymond James analyst Justin Jenkins upgraded Cheniere Energy (LNG) to Outperform from Market Perform with a $71 price target. In a research note to investors, Jenkins says Cheniere's strong track record of execution has solidified its position as a U.S. LNG market leader. The analyst sees Cheniere Energy as moving closer to "runrate cash flow" and believes upside potential exists given the optionality at Cheniere Energy vs. Cheniere Energy Partners (CQP) and sees the set-up into 2020 as "positive."
REZI Resideo
$8.88

-6.29 (-41.46%)

10/23/19
OPCO
10/23/19
DOWNGRADE
OPCO
Perform
Resideo downgraded to Perform from Outperform at Oppenheimer
10/23/19
OPCO
10/23/19
DOWNGRADE
OPCO
Perform
Resideo downgraded to Perform on revised guidance at Oppenheimer
As previously reported, Oppenheimer analyst Ian Zaffino downgraded Resideo to Perform from Outperform after the company, once again, revised guidance negatively. This time, the company pre-announced Q3 and lowered fiscal year 2019 guidance, based on a slowdown in the RTS gas combustion business and an unfavorable change-over in thermostats, he notes.
10/23/19
BOFA
10/23/19
DOWNGRADE
Target $14
BOFA
Neutral
BofA/Merrill downgrades Resideo to Neutral on 'disappointing' news
BofA/Merrill analyst John Lovallo downgraded Resideo Technologies to Neutral from Buy with a price target of $14, down from $21. The stock in morning trading is down 41%, or $6.32, to $8.91. The company last night preannounced "very disappointing" preliminary Q3, lowered its expectations for 2019, and announced the departure of CFO Joe Ragan, Lovallo tells investors in a research note. Management credibility has become a significant challenge for the stock, says the analyst, who believes the new CFO will have a "heavy load to bear" in turning Resideo around.
10/23/19
BOFA
10/23/19
DOWNGRADE
BOFA
Neutral
Resideo downgraded to Neutral from Buy at BofA/Merrill
NOW ServiceNow
$224.99

-3.27 (-1.43%)

10/23/19
COWN
10/23/19
NO CHANGE
Target $315
COWN
Outperform
ServiceNow new CEO well-suited for next growth phase, says Cowen
Cowen analyst J. Derrick Wood noted ServiceNow (NOW) announced its CEO would be leaving to be CEO of Nike (NKE) and that ex-SAP (SAP) CEO Bill McDermott will take his place. The company also preannounced its Q3 results, beating estimates on billings growth and raising guidance on the high-end. The analyst noted the CEO change was a surprise but he believes McDermott's skill set should be well-suited for the company's next growth phase. Wood reiterated his Outperform rating and $315 price target on ServiceNow shares.
10/23/19
JEFF
10/23/19
NO CHANGE
Target $330
JEFF
Buy
ServiceNow shares may remain range-bound, says Jefferies
While ServiceNow's preliminary Q3 results beat subscriber billings expectations, the implied Q4 subscription revenue and billings guidance were both below consensus, Jefferies analyst Samad Samana tells investors in a research note. The analyst is not sure the Q3 results will be enough to drive shares higher in the near-term given the implied Q4 guidance, the uncertainty created by ServiceNow's leadership changes, and concerns facing high-growth software. However, he sees Bill McDermott as a "solid" CEO hire given his "successful track record in enterprise software." Samana keeps a Buy rating on ServiceNow shares with a $330 price target.
10/23/19
MACQ
10/23/19
NO CHANGE
Target $243
MACQ
Outperform
Macquarie a buyer of ServiceNow, says Bill McDermott a 'huge win'
Macquarie analyst Sarah Hindlian says that while she understands the uncertainty in ServiceNow shares around the departure of John Donahoe and the lack of a CFO appointment, she thinks the preliminary results "spoke volumes against the bear case." Further, the analyst sees incoming CEO Bill McDermott "as one of the best executives available in enterprise software." McDermott is a "huge win," contends Hindlian, who is a buyer of ServiceNow shares into today's conference call. She has a Buy rating on the stock with a $335 price target.
10/23/19
UBSW
10/23/19
NO CHANGE
Target $232
UBSW
Buy
ServiceNow stock price attractive following aftermarket decline, says UBS
UBS analyst Jennifer Lowe is keeping her Buy rating and $232 price target on ServiceNow (NOW) after the stock fell afterhours yesterday on the news that its CEO John Donahoe is leaving for a CEO post at Nike (NKE). The analyst notes that the company also pre-announced Q3 ahead of consensus while its FY19 outlook indicates no change to Q4 guidance. Lowe adds that although ServiceNow is faced with new CEO transition risk, the former SAP CEO Bill McDermott is also "seasoned", and the stock is "attractive" at a 29-times enterprise value to expected 2020 free cash flow.
KSS Kohl's
$52.30

-0.66 (-1.25%)

10/23/19
EVER
10/23/19
DOWNGRADE
EVER
In Line
Kohl's downgraded to In Line from Outperform at Evercore ISI
08/21/19
GUGG
08/21/19
NO CHANGE
Target $60
GUGG
Buy
Kohl's [price target lowered to $60 from $70 at Guggenheim
Guggenheim analyst Robert Drbul lowered his price target for Kohl's to $60 from $70 to reflect lower sales/more pronounced gross margin contraction following quarterly results. The analyst reiterates a Buy rating on the shares as he believes management has the playbook to drive positive comps in the second half of 2019.
08/21/19
FBCO
08/21/19
NO CHANGE
Target $51
FBCO
Neutral
Kohl's price target lowered to $51 from $57 at Credit Suisse
Credit Suisse analyst Michael Binetti lowered his price target for Kohl's (KSS) to $51 from $57 following a mix Q2. While the analyst notes that Amazon (AMZN) comments don't offer much for bull case, he believes Amazon awareness should build as Kohl's ramps marketing and as consumers start trafficking stores during back-to-school. He reiterates a Neutral rating on Kohl's shares.
08/21/19
DBAB
08/21/19
NO CHANGE
Target $52
DBAB
Hold
Kohl's price target lowered to $52 from $58 at Deutsche Bank
Deutsche Bank analyst Paul Trussell maintained a Hold rating on Kohl's and lowered his price target to $52 from $58 following the company's Q2 results. Though EPS beat slightly, gross margin fell short of expectations, which Trussell says raises concerns around the overall promotional environment. Trussell tells investors that he believes reiterated full-year EPS and comp guidance is viewed to be too aggressive as it assumes sustaining positive comps in the back half along with an improvement in margin trends, and feels investors are taking a wait-and-see approach tot he Amazon Returns program given the increasing store payroll expenses that are necessary to support it.

TODAY'S FREE FLY STORIES

WFC

Wells Fargo

$53.80

0.3 (0.56%)

, AAPL

Apple

$265.73

3.07 (1.17%)

10:01
11/16/19
11/16
10:01
11/16/19
10:01
Periodicals
Berkshire Hathaway inactive with record cash hoard, Barron's says »

Berkshire Hathaway…

WFC

Wells Fargo

$53.80

0.3 (0.56%)

AAPL

Apple

$265.73

3.07 (1.17%)

OXY

Occidental Petroleum

$38.94

1.18 (3.13%)

BRK.B

Berkshire Hathaway

$219.74

0.38 (0.17%)

BRK.A

Berkshire Hathaway

$329,361.11

266.11 (0.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Jan

DIS

Disney

$144.63

-2.56 (-1.74%)

09:43
11/16/19
11/16
09:43
11/16/19
09:43
Periodicals
Disney+ may not be able to hold onto huge number of subs, Barron's says »

While Disney's (DIS)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDT

Medtronic

$112.11

2.9 (2.66%)

09:27
11/16/19
11/16
09:27
11/16/19
09:27
Periodicals
Medtronic shares 'could rise even more,' Barron's says »

Barron's recommended…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

BR

Broadridge

$119.80

0.485 (0.41%)

09:18
11/16/19
11/16
09:18
11/16/19
09:18
Periodicals
Broadridge a defensive name that can withstand slowdown, Barron's says »

Broadridge Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MCD

McDonald's

$193.95

-0.02 (-0.01%)

, MDT

Medtronic

$112.11

2.9 (2.66%)

09:07
11/16/19
11/16
09:07
11/16/19
09:07
Periodicals
Barron's suggests dividend stocks for retirement savers »

In this week's…

MCD

McDonald's

$193.95

-0.02 (-0.01%)

MDT

Medtronic

$112.11

2.9 (2.66%)

KO

Coca-Cola

$52.67

0.03 (0.06%)

PRU

Prudential

$93.61

0.82 (0.88%)

SYF

Synchrony

$37.05

0.34 (0.93%)

KEY

KeyCorp

$18.96

0.1 (0.53%)

T

AT&T

$39.49

0.53 (1.36%)

AMGN

Amgen

$220.84

2.29 (1.05%)

CSCO

Cisco

$45.10

0.18 (0.40%)

RCL

Royal Caribbean

$117.91

2.69 (2.33%)

MRK

Merck

$84.89

0.33 (0.39%)

JNJ

Johnson & Johnson

$134.97

3.99 (3.05%)

MSFT

Microsoft

$149.95

1.89 (1.28%)

JPM

JPMorgan

$129.51

0.83 (0.65%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

  • 18

    Nov

  • 19

    Nov

  • 19

    Nov

  • 20

    Nov

  • 21

    Nov

  • 22

    Nov

  • 02

    Dec

  • 04

    Dec

  • 07

    Dec

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 10

    Dec

  • 10

    Dec

  • 14

    Jan

  • 21

    Jan

  • 23

    Jan

  • 24

    Jan

  • 24

    Jan

  • 29

    Jan

  • 05

    Feb

  • 12

    Feb

  • 14

    Mar

AMZN

Amazon.com

$1,737.49

-17.22 (-0.98%)

, MSFT

Microsoft

$149.95

1.89 (1.28%)

08:54
11/16/19
11/16
08:54
11/16/19
08:54
On The Fly
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AMZN

Amazon.com

$1,737.49

-17.22 (-0.98%)

MSFT

Microsoft

$149.95

1.89 (1.28%)

AAPL

Apple

$265.73

3.07 (1.17%)

CI

Cigna

$196.08

6.41 (3.38%)

CNC

Centene

$57.57

2.91 (5.32%)

CVS

CVS Health

$74.27

1.34 (1.84%)

HUM

Humana

$335.43

17.48 (5.50%)

UNH

UnitedHealth

$269.44

13.68 (5.35%)

WCG

WellCare

$312.01

10.155 (3.36%)

HNT

Health Net

$0.00

(0.00%)

MOH

Molina Healthcare

$129.60

7.3 (5.97%)

ANTM

Anthem

$298.18

16.14 (5.72%)

HCA

HCA Healthcare

$137.98

3.51 (2.61%)

CYH

Community Health

$3.12

0.25 (8.71%)

LPNT

LifePoint

$0.00

(0.00%)

UHS

Universal Health

$144.30

3.13 (2.22%)

THC

Tenet

$30.55

1.08 (3.66%)

GM

General Motors

$36.87

0.07 (0.19%)

FCAU

Fiat Chrysler

$16.02

0.04 (0.25%)

TM

Toyota

$144.29

1.16 (0.81%)

F

Ford

$8.96

0.16 (1.82%)

HMC

Honda

$28.99

0.155 (0.54%)

VWAGY

Volkswagen

$0.00

(0.00%)

BMWYY

BMW

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 19

    Nov

  • 20

    Nov

  • 20

    Nov

  • 22

    Nov

  • 04

    Dec

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 13

    Dec

  • 04

    Feb

  • 06

    Feb

MDCO

The Medicines Co.

$51.92

1.03 (2.02%)

04:55
11/16/19
11/16
04:55
11/16/19
04:55
Conference/Events
Roth Capital pharmaceuticals analysts to hold a luncheon »

Analysts host Dr. John…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Nov

CVET

Covetrus

$14.93

1.44 (10.67%)

18:41
11/15/19
11/15
18:41
11/15/19
18:41
Hot Stocks
Covetrus CEO: We're a leader in the humanization of pets »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMCSK

Comcast

$0.00

(0.00%)

, CMCSA

Comcast

$44.54

-0.93 (-2.05%)

18:02
11/15/19
11/15
18:02
11/15/19
18:02
Hot Stocks
Viacom extends cable deal for 'The Office' through 2025 »

Viacom (VIA) announced…

CMCSK

Comcast

$0.00

(0.00%)

CMCSA

Comcast

$44.54

-0.93 (-2.05%)

VIAB

Viacom

$23.07

0.59 (2.62%)

VIA

Viacom

$26.59

1.28 (5.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

CWK

Cushman & Wakefield

$19.10

0.1 (0.53%)

17:48
11/15/19
11/15
17:48
11/15/19
17:48
Hot Stocks
Cushman & Wakefield CEO sells 84.6K share of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

LMT

Lockheed Martin

$393.52

3.305 (0.85%)

17:39
11/15/19
11/15
17:39
11/15/19
17:39
Hot Stocks
Lockheed Martin awarded maximum $3.33B Air Force contract »

Lockheed Martin has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ESCA

Escalade

$10.90

-0.09 (-0.82%)

17:38
11/15/19
11/15
17:38
11/15/19
17:38
Hot Stocks
Escalade CEO Fetherman to retire »

Escalade announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CZR

Caesars

$12.96

0.1 (0.78%)

, ERI

Eldorado Resorts

$52.10

0.93 (1.82%)

17:38
11/15/19
11/15
17:38
11/15/19
17:38
Hot Stocks
Eldorado, Caesars stockholders approve Eldorado acquisition of Caesars »

Eldorado Resorts (ERI)…

CZR

Caesars

$12.96

0.1 (0.78%)

ERI

Eldorado Resorts

$52.10

0.93 (1.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

EGRX

Eagle Pharmaceuticals

$57.24

0.55 (0.97%)

17:15
11/15/19
11/15
17:15
11/15/19
17:15
Syndicate
Breaking Syndicate news story on Eagle Pharmaceuticals »

Eagle Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FN

Fabrinet

$60.82

0.84 (1.40%)

17:11
11/15/19
11/15
17:11
11/15/19
17:11
Hot Stocks
Fabrinet President Gill sells 12.9K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

TEUM

Pareteum

$0.38

-0.0209 (-5.21%)

17:05
11/15/19
11/15
17:05
11/15/19
17:05
Hot Stocks
Pareteum receives noncompliance notice from Nasdaq »

Pareteum announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HEXO

Hexo

$1.78

-0.1 (-5.32%)

17:00
11/15/19
11/15
17:00
11/15/19
17:00
Hot Stocks
Hexo was cannabis was being grown in unlicensed space at Niagara site »

HEXO Corp provided…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGN

Amgen

$220.84

2.29 (1.05%)

, CELG

Celgene

$110.02

-0.01 (-0.01%)

16:57
11/15/19
11/15
16:57
11/15/19
16:57
Hot Stocks
Bristol-Myers gets FTC clearance for Celgene acquisition »

Bristol-Myers Squibb…

AMGN

Amgen

$220.84

2.29 (1.05%)

CELG

Celgene

$110.02

-0.01 (-0.01%)

BMY

Bristol-Myers

$58.61

0.11 (0.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

  • 04

    Dec

  • 07

    Dec

  • 25

    Mar

  • 04

    Apr

RAVE

Rave Restaurant

$1.44

-0.79 (-35.43%)

16:47
11/15/19
11/15
16:47
11/15/19
16:47
Hot Stocks
BBRC Asset Management reports 6.6% passive stake in Rave Restaurant »

BBRC Asset Management …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHAP

Chaparral Energy

$0.89

-0.0521 (-5.52%)

16:46
11/15/19
11/15
16:46
11/15/19
16:46
Hot Stocks
Chaparral Energy receives continued listing standard notice from NYSE »

Chaparral Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:45
11/15/19
11/15
16:45
11/15/19
16:45
General news
Breaking General news story  »

San Francisco Federal…

16:45
11/15/19
11/15
16:45
11/15/19
16:45
General news
Breaking General news story  »

San Francisco Federal…

CI

Cigna

$196.08

6.41 (3.38%)

, CNC

Centene

$57.57

2.91 (5.32%)

16:41
11/15/19
11/15
16:41
11/15/19
16:41
On The Fly
Fly Intel: Wall Street's top stories for Friday »

Stocks closed out the…

CI

Cigna

$196.08

6.41 (3.38%)

CNC

Centene

$57.57

2.91 (5.32%)

CVS

CVS Health

$74.27

1.34 (1.84%)

HUM

Humana

$335.43

17.48 (5.50%)

UNH

UnitedHealth

$269.44

13.68 (5.35%)

WCG

WellCare

$312.01

10.155 (3.36%)

HNT

Health Net

$0.00

(0.00%)

MOH

Molina Healthcare

$129.60

7.3 (5.97%)

ANTM

Anthem

$298.18

16.14 (5.72%)

HCA

HCA Healthcare

$137.98

3.51 (2.61%)

CYH

Community Health

$3.12

0.25 (8.71%)

LPNT

LifePoint

$0.00

(0.00%)

UHS

Universal Health

$144.30

3.13 (2.22%)

NVDA

Nvidia

$204.12

-5.76 (-2.74%)

AMZN

Amazon.com

$1,739.33

-15.38 (-0.88%)

MSFT

Microsoft

$149.95

1.89 (1.28%)

UAA

Under Armour

$17.78

0.65 (3.79%)

UA

Under Armour

$15.97

0.41 (2.64%)

AMRN

Amarin

$23.99

2.5 (11.63%)

JNJ

Johnson & Johnson

$134.97

3.99 (3.05%)

GOOG

Alphabet

$1,334.01

21.82 (1.66%)

GOOGL

Alphabet Class A

$1,333.33

23.54 (1.80%)

ORCL

Oracle

$56.43

0.33 (0.59%)

RH

RH

$188.73

13.535 (7.73%)

QGEN

Qiagen

$40.56

3.255 (8.73%)

FTCH

Farfetch

$9.66

2.17 (28.97%)

THC

Tenet

$30.55

1.08 (3.66%)

TORC

resTORbio

$1.10

-6.83 (-86.13%)

ACB

Aurora Cannabis

$2.72

-0.57 (-17.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 19

    Nov

  • 19

    Nov

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 22

    Nov

  • 04

    Dec

  • 07

    Dec

  • 09

    Dec

  • 09

    Dec

  • 13

    Dec

  • 28

    Dec

  • 06

    Jan

  • 21

    Jan

  • 06

    Feb

NYT

New York Times

$31.60

0.44 (1.41%)

16:41
11/15/19
11/15
16:41
11/15/19
16:41
Hot Stocks
New York Times CEO sells 66,000 class A common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

WEX

Wex

$200.52

4.61 (2.35%)

16:41
11/15/19
11/15
16:41
11/15/19
16:41
Hot Stocks
Wex director Morris sells 3K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.